title: Evidence of an insulin generated pyruvate dehydrogenase stimulating factor in rat brain plasma membranes.
abstract: 1. The results of this study indicates that the binding of insulin to brain plasma membranes activates a membrane protease which, by a trypsin like mechanism, produces a soluble factor that modulates the PDH behaviour when added to brain mitochondria. 2. The supernatant from brain plasma membranes incubated with 0.5 mg/ml trypsin added to mitochondria increases PDH activity levels and cancels PDH inhibition by NaF, as has already been seen when the plasma membranes are incubated with 25 microU/ml insulin. No such effects are obtained when the incubation is run out with 0.5 mg/ml chymotrypsin. 3. The supernatants from insulin or trypsin treated plasma membranes retain their activating properties on mitochondrial PDH also after dansylation; from these preparations a dansylated active on PDH material was separated by monodimensional chromatography on HPTLC silica Gel plates, using chloroform/1-butanol (93:7 v/v) as a solvent. 4. Insulin incubation of plasma membranes pretreated with protease inhibitors (leupeptin, phenylmethylsulfonylfluoride) or with exogenous trypsin, but not chymotrypsin substrates (esters of arginine and tyrosine) yields an inactive supernatant on PDH. 5. Insulin treated plasma membrane supernatants lose all stimulating properties on PDH after incubation for 1 hr with 2 mg/ml trypsin or chymotrypsin.
authors.affiliation: Istituto di Chimica Biologica, Università di Torino, Italia.
authors.forename: M T
authors.initials: MT
authors.lastname: Rinaudo
authors.forename: M
authors.initials: M
authors.lastname: Curto
authors.forename: R
authors.initials: R
authors.lastname: Bruno
authors.forename: C
authors.initials: C
authors.lastname: Marino
authors.forename: V
authors.initials: V
authors.lastname: Rossetti
authors.forename: M
authors.initials: M
authors.lastname: Mostert
mesh_terms: D000818:Animals; D001921:Brain / Q000201:enzymology*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002918:Chymotrypsin / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism*; D051381:Rats; D013347:Subcellular Fractions / Q000187:drug effects / Q000201:enzymology; D014357:Trypsin / Q000494:pharmacology
chemical_list: D007328:Insulin; D011768:Pyruvate Dehydrogenase Complex; C029131:pyruvate dehydrogenase activator; D002918:Chymotrypsin; D014357:Trypsin